Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
GDS Holdings
GDS
$6.38B
| $124K | ﹤0.01% |
13,600
-400
| -3% | -$4.04K |
|
3252
Perspective Therapeutics
CATX
$339M
| $123K | ﹤0.01% |
30,675
-6,090
| -17% | -$17.1K |
|
|
RENT
3253
Rent the Runway
RENT
$122M
| $123K | ﹤0.01% |
11,620
+1,230
| +12% | +$15.2K |
|
3254
Hyperfine
HYPR
$97.5M
| $122K | ﹤0.01% |
+108,681
| New | +$151K |
|
3255
ReNew
RNW
$2.27B
| $122K | ﹤0.01% |
15,900
-26,900
| -63% | -$166K |
|
3256
Aveanna Healthcare
AVAH
$2.03B
| $121K | ﹤0.01% |
45,300
-6,200
| -12% | -$11.8K |
|
|
NBP
3257
NovaBridge Biosciences American Depositary Shares
NBP
$197M
| $121K | ﹤0.01% |
63,800
| – | – |
|
3258
CPI Aerostructures
CVU
$68.2M
| $120K | ﹤0.01% |
44,000
-12,390
| -22% | -$34.4K |
|
3259
Worksport
WKSP
$10.9M
| $119K | ﹤0.01% |
7,964
+3,944
| +98% | +$62.6K |
|
|
DWTX
3260
Dogwood Therapeutics
DWTX
$58.9M
| $119K | ﹤0.01% |
8,268
+7,708
| +1,376% | +$130K |
|
3261
Inuvo
INUV
$16.8M
| $118K | ﹤0.01% |
27,840
+5,900
| +27% | +$15.4K |
|
3262
IZEA Worldwide
IZEA
$59M
| $118K | ﹤0.01% |
58,903
+6,400
| +12% | +$14.5K |
|
3263
Dakota Gold
DC
$739M
| $117K | ﹤0.01% |
44,600
+5,900
| +15% | +$15.8K |
|
|
IPM
3264
Intelligent Protection Management Corp
IPM
$23.7M
| $117K | ﹤0.01% |
50,100
+3,780
| +8% | +$7.02K |
|
|
TOUR
3265
Tuniu
TOUR
$55.9M
| $116K | ﹤0.01% |
17,233
| – | – |
|
3266
Vor Biopharma
VOR
$1.28B
| $116K | ﹤0.01% |
2,580
+755
| +41% | +$31.2K |
|
|
EGIO
3267
DELISTED
Edgio, Inc. Common Stock
EGIO
| $116K | ﹤0.01% |
8,465
-10,834
| -56% | -$267K |
|
|
DDI
3268
DoubleDown Interactive
DDI
$590M
| $115K | ﹤0.01% |
+15,595
| New | +$129K |
|
3269
Diana Shipping Inc Warrants exp 2026
DSX.WS
$6.16M
| $115K | ﹤0.01% |
+411,535
| New | +$134K |
|
3270
First Guaranty Bancshares
FGBI
$158M
| $115K | ﹤0.01% |
10,383
-2,100
| -17% | -$21.8K |
|
3271
Xilio Therapeutics
XLO
$61M
| $115K | ﹤0.01% |
14,979
+13,500
| +913% | +$267K |
|
|
AGRX
3272
DELISTED
Agile Therapeutics
AGRX
| $115K | ﹤0.01% |
+59,200
| New | +$119K |
|
3273
Mexco Energy
MXC
$19.3M
| $114K | ﹤0.01% |
12,500
+2,100
| +20% | +$23.8K |
|
|
GP
3274
GreenPower Motor Co
GP
$10.5M
| $113K | ﹤0.01% |
3,602
+2,042
| +131% | +$61.9K |
|
|
VIVS
3275
VivoSim Labs
VIVS
$1.15M
| $113K | ﹤0.01% |
8,457
-642
| -7% | -$9.54K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.